Parabolic Drugs Ltd. - Research Center
533211 PARABDRUGS Group (Z) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 20 | Mar ' 18 | Mar ' 17 | Mar ' 16 | Mar ' 15 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 61.89 | 61.89 | 61.89 | 61.89 | 61.89 |
| Share application money | - | 26.00 | 26.00 | 26.00 | 26.00 |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | -978.27 | -934.22 | -877.22 | -769.15 | -283.96 |
| Loan funds | |||||
| Secured loans | 156.27 | 948.78 | 943.69 | 937.47 | 925.00 |
| Unsecured loans | - | 35.33 | 35.78 | 34.28 | 32.49 |
| Total | -760.11 | 137.78 | 190.14 | 290.49 | 761.42 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 283.44 | 480.39 | 482.00 | 482.74 | 485.35 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | - | 154.02 | 133.16 | 111.55 | 90.22 |
| Net block | 283.44 | 326.37 | 348.84 | 371.19 | 395.13 |
| Capital work-in-progress | - | 6.52 | 6.52 | 6.52 | 6.52 |
| Investments | 6.34 | 6.34 | 6.33 | 6.33 | 6.32 |
| Net current assets | |||||
| Current assets, loans & advances | 58.54 | 79.72 | 131.69 | 192.97 | 542.16 |
| Less : current liabilities & provisions | 1,108.43 | 281.16 | 303.24 | 286.51 | 188.72 |
| Total net current assets | -1,049.89 | -201.45 | -171.54 | -93.55 | 353.45 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | -760.11 | 137.78 | 190.14 | 290.49 | 761.42 |
| Notes: | |||||
| Book value of unquoted investments | - | 6.34 | 6.33 | 6.33 | 6.32 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | - | 6.25 | - | - | 8.33 |
| Number of equity sharesoutstanding (Lacs) | 618.90 | 618.92 | 618.92 | 618.92 | 618.92 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis